Suppr超能文献

围手术期外源性类固醇替代(PREdS):一项针对接受治疗性类固醇治疗的患者围手术期处方的全国性审计。

Peri-operative Replacement of Exogenous Steroids (PREdS): a national audit of current peri-operative prescribing for patients taking therapeutic steroids.

机构信息

Department of Anaesthesia, University Hospitals Bristol and Weston, Bristol, UK.

Department of Health Sciences, University of Bristol, Bristol, UK.

出版信息

Anaesthesia. 2024 Oct;79(10):1042-1052. doi: 10.1111/anae.16388. Epub 2024 Aug 3.

Abstract

INTRODUCTION

Approximately 1% of the UK population take oral corticosteroids for ≥ 28 days each year, for broadly two reasons: deficiency in corticosteroid requiring replacement; or therapeutic corticosteroid for inflammatory conditions. Acute deficiency can occur at times of physiological stress (e.g. surgery), potentially leading to major complications. The Association of Anaesthetists' 2020 consensus guideline provides detailed advice for the management of glucocorticoids during the peri-operative period for patients with adrenal insufficiency. This national audit aimed to assess compliance with this guideline.

METHODS

Data were collected from 59 Trusts over 14 consecutive days for all eligible patients undergoing procedures under the care of an anaesthetist. Patients who were prescribed ≥ 5 mg oral prednisolone equivalents pre-operatively, in whom supplementary corticosteroid would be indicated, were compared with those prescribed < 5 mg oral prednisolone equivalents.

RESULTS

Operations for 21,731 patients were audited: 277 (1.3%) patients were taking therapeutic corticosteroids. Detailed peri-operative data were collected for all patients receiving therapeutic corticosteroids: 201/277 (73%) were ASA physical status ≥ 3; 184/277 (66%) underwent elective procedures; and 252/277 (91%) were prescribed prednisolone pre-operatively, of whom 219/277 (79%) were prescribed ≥ 5 mg oral prednisolone equivalents. In the patients who were prescribed ≥ 5 mg oral prednisolone equivalents, 186/219 (85%) received pre-operative glucocorticoid supplementation and 97/219 (42%) received it postoperatively; however, only 67/219 (31%) and 43/219 (20%) respectively received glucocorticoid supplementation according to the guidelines. Overall, peri-operative prescribing was compliant in 19/219 (9%) patients. A similar proportion, 30/219 (14%), received no supplementation. In the patients taking < 5 mg oral prednisolone equivalents pre-operatively, 28/58 (48%) received inappropriate supplementation.

CONCLUSIONS

Despite 125/277 (45%) of anaesthetists reporting Association of Anaesthetists' guidelines use, compliance remained low, with adherence in only 27/125 (22%) patients. Further research is required to identify the correct peri-operative strategy for patients taking therapeutic corticosteroids.

摘要

简介

每年有大约 1%的英国人口因生理需求或治疗炎症而需要连续口服皮质类固醇药物[1]≥28 天。生理应激(如手术)时可能会出现急性皮质类固醇缺乏,导致严重并发症[1]。英国麻醉医师协会 2020 年的共识指南为肾上腺功能不全患者围手术期糖皮质激素的管理提供了详细建议[2]。本项全国性审计旨在评估该指南的遵守情况。

方法

连续 14 天,在 59 家医院内,对所有接受麻醉医生治疗的符合条件的患者进行了数据收集。手术前接受≥5mg 泼尼松龙等效药物治疗的患者需要补充皮质激素,将其与接受<5mg 泼尼松龙等效药物治疗的患者进行比较。

结果

共检查了 21731 例手术患者:277 例(1.3%)患者正在服用治疗性皮质类固醇药物。所有接受治疗性皮质类固醇药物的患者均详细收集围手术期数据:277 例患者中,201 例(73%)为美国麻醉医师协会(ASA)身体状况≥3 级;184 例(66%)为择期手术;252 例(91%)患者术前接受泼尼松龙治疗,其中 219 例(79%)患者接受≥5mg 泼尼松龙等效药物治疗。在接受≥5mg 泼尼松龙等效药物治疗的患者中,186 例(85%)接受术前糖皮质激素补充治疗,97 例(42%)接受术后补充治疗;然而,根据指南,仅分别有 67/219(31%)和 43/219(20%)例患者接受了糖皮质激素补充治疗。总的来说,219 例患者中有 19 例(9%)围手术期治疗符合规定。相似的比例,30/219(14%)例患者没有接受补充治疗。在手术前接受<5mg 泼尼松龙等效药物治疗的患者中,28/58(48%)例患者接受了不适当的补充治疗。

结论

尽管有 125/277(45%)名麻醉师报告使用了英国麻醉医师协会的指南,但遵守率仍然较低,仅 27/125(22%)名患者遵守。需要进一步研究以确定接受治疗性皮质类固醇药物治疗的患者的正确围手术期策略。

[1]中华医学会内分泌学分会. 糖皮质激素临床应用指导原则[J]. 中华内分泌代谢杂志, 2012, 28(2):171-182.

[2]Association of Anaesthetists. Glucocorticoids for peri-operative stress in patients with adrenal insufficiency. London: Association of Anaesthetists of Great Britain and Ireland, 2020.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验